Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T19:12:50.367Z.
Calculation as of: 2026-10-06T19:12:50.367Z.
Quote observation: 2026-10-06T19:10:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 82cee4a6010f8650e239c44e6fa86f6cad5a1cacb0b867e980d6d40a64789328
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Nautilus Biotechnolgy, Inc.
Market Cap
$228.42M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$228.31M
Operating Cash Flow Yield
N/A
TTM Avg
1.61%
3Y Avg
1.61%
5Y Avg
1.61%
Market Cap
$229.29M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$232.74M
Operating Cash Flow Yield
N/A
TTM Avg
17.96%
3Y Avg
12.82%
5Y Avg
11.02%
Market Cap
$222.28M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$221.45M
Operating Cash Flow Yield
N/A
TTM Avg
14.77%
3Y Avg
14.64%
5Y Avg
14.64%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nautilus Biotechnolgy, Inc. (NAUT) | $228.42M | N/A | N/A | N/A | N/A |
| MacroGenics, Inc. (MGNX)vs › | $228.31M | N/A | 1.61% | 1.61% | 1.61% |
| BioAge Labs Inc. (BIOA)vs › | $229.29M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $225.89M | N/A | N/A | N/A | N/A |
| Vogenx Inc. (VOGX)vs › | $225.20M | N/A | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $232.74M | N/A | 17.96% | 12.82% | 11.02% |
| Profound Medical Corp. (PROF)vs › | $222.28M | N/A | N/A | N/A | N/A |
| Keros Therapeutics, Inc. (KROS)vs › | $221.45M | N/A | 14.77% | 14.64% | 14.64% |
| InflaRx N.V. (IFRX)vs › | $233.46M | N/A | N/A | N/A | N/A |
| Utah Medical Products, Inc. (UTMD)vs › | $235.83M | 5.02% | 6.66% | 7.54% | 7.09% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
